EULAR 2025 highlights… EULAR 2025 Highlights – SLE and APS 18 Jul 2025 Preliminary results of CD19/BCMA Dual-Targeting FasTCAR-T Cells GC012F (AZD0120) in patients with refractory Systemic Lupus Erythematosus-an open-label, single-arm study Abstract format and assignment number: Oral presentation OP0074 Date: Wednesday, 11…
ACR Highlights… ACR Convergence 2024 Highlights – SLE and APS 19 Dec 202419 Dec 2024 A Novel, Potent and Selective TLR7/8 Small Molecule Inhibitor Blocks TLR7/8 Pathway in the Presence of HCQ and Demonstrates Robust Preclinical Efficacy in Lupus Models Abstract format and assignment number:…
EULAR 2024 Highlights… EULAR 2024 Highlights – SLE and APS 21 Jul 202422 Jul 2024 Author: Cristiana Sieiro Santos Taubmann et al. (OP0027) presented data on the long-term safety and efficacy of autologous CD19 CAR T cell therapy in patients with SLE, IIM and SSc, showing that…
ACR Highlights… ACR Convergence Highlights 2023 – SLE and APS 9 Dec 20239 Dec 2023 Author: Anastasia Madenidou Schett et al. (0607) followed up 8 SLE patients who received treatment with CD19 CAR T cell therapy. Five patients had a follow-up of more than one year…